To Address “Changed Circumstances” After Institution, USPTO Director Extends Deadline for Seeking Director Review of Institution Decisions

July 13, 2026

Reading Time : 3 min

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

Prior to institution, a judge in the related district court litigation had dismissed the complaint with respect to the challenged claims without prejudice under § 101 and granted the Patent Owner leave to amend. The Patent Owner filed its amended complaint in district court in June 2025, and the PTAB instituted inter partes review in December 2025. In February 2026, the district court again dismissed the claims on § 101 grounds, this time with prejudice and without granting leave to amend. Because the patents were now invalid, Patent Owner moved to terminate the IPR proceedings in April 2026. The PTAB denied the motion, however, citing a lack of authority to terminate proceedings for discretionary reasons. Patent Owner then submitted an email to the Director seeking guidance on how to request Director Review of the termination denial given that such decisions are not one of the expressly permitted bases for seeking Director Review under 37 C.F.R. § 42.75(a).

After agreeing that the rules do not permit seeking Director Review on the motion to terminate, Director Squires provided a basis for seeking review of the underlying institution decisions instead, even though the deadline for doing so had long passed. Recognizing that parties should “be able to seasonably raise issues affecting institution,” Director Squires first applied the “waiver” mechanism of 37 C.F.R. § 42.5 to extend the deadline to request Director Review of a decision to institute trial to thirty days, making it consistent with the deadlines to request Director Review for both institution denials and final written decisions. In addition, Director Squires “recognize[d] that changed circumstances can surface after the deadline to file a request for Director Review …but before trial has progressed meaningfully.” He then noted that, in the past, he typically “initiated a sua sponte Director Review to determine the impact on institution,” which “is not always the most efficient process.” To redress these situations, the Director explained that certain other “exceptional circumstances” may warrant a further deadline extension, so long as trial has not progressed meaningfully. Those circumstances include the dismissal of all or substantially all claims in a co-pending litigation, findings of fact or law that render all or substantially all challenged claims invalid in litigation, or a violation of a Sotera stipulation. Here, even though more than thirty days had passed since institution, the Director found that the district court’s dismissal of the challenged claims for patent ineligibility under § 101 was an “exceptional circumstance” warranting Director Review.

On the merits of the Review itself, the Director found that termination of the IPR proceedings was appropriate and vacated the institution decisions on that basis. Because the district court found all of the challenged claims to be ineligible—and the PTAB and parties had expended limited resources in the IPR proceedings thus far—the Director reasoned that it would be more efficient to terminate the IPRs and reserve any invalidity issues for the district court on remand to the extent necessary. Accordingly, the Director vacated the PTAB’s decisions granting institution and further ordered denial of the Petitions and no institution of trial.

Notably, for efficiency, the Director issued the current decision sua sponte instead of requiring Patent Owner to file a formal request for review under his new rules. However, going forward, the Director instructed parties seeking an extension based on “exceptional circumstances” to send an email to Director_PTABDecision_Review@uspto.gov. The email should “provide a short summary of no more than three sentences” explaining the exceptional circumstances, to which “[t]he other parties to the case will be given an opportunity to respond.”

Practice Tip: The extended request window to thirty days and formalized “exceptional circumstances” extension now provides parties with more time to formally request Director Review of a decision granting institution, including in response to late-surfacing developments in a district court litigation. Going forward, if a party believes that “exceptional circumstances” warrant an extension to request Director Review, that party will have the opportunity to address those circumstances in three sentences or less as part of the formal request process.

Light & Wonder, Inc. v. Evolution Malta Ltd., IPR2025-01072, Paper 30 (P.T.A.B. June 22, 2026)

Share This Insight

Previous Entries

IP Newsflash

July 13, 2026

In a precedential and sua sponte Director Review decision, USPTO Director Squires recently vacated three related institution decisions nearly six months after institution where a district court later found the challenged claims invalid. Because the fourteen-day deadline to request Director Review of the institution decisions had passed, the Director used this opportunity to formally extend the deadline in two ways. First, he extended the fourteen-day deadline under 37 C.F.R. § 42.75(c)(1) to thirty days, which “puts requests for Director Review of decisions to institute trial on equal footing to requests for Director Review of final decisions or decisions not to institute trial.” Second, he outlined certain “exceptional circumstances” that warrant a further extension of the deadline to account for changes in the case that “surface after the deadline.” In the case at hand, the Director found the district court’s invalidity finding to be such an “exceptional circumstance” and ultimately initiated review and vacated the institution decisions on that basis.

...

Read More

IP Newsflash

June 5, 2026

The Supreme Court unanimously held that for a complaint of induced infringement, a patent owner must allege that the accused infringer took affirmative, not passive, steps to encourage direct infringement. Thus, where a generic drug has a skinny label, to induce infringement of the carved-out patented use of the drug, the generic company must have taken steps that were designed to cause others to perform the patented use, not just steps that could cause such conduct.

...

Read More

IP Newsflash

May 07, 2026

The Northern District of Illinois granted a summary judgment motion of no invalidity based on indefiniteness because the qualitative terms like “sufficiently slow” and “desired period of time” were definite when viewed in light of the surrounding claim language and specification.

...

Read More

IP Newsflash

April 9, 2026

In the April 1, 2026 edition of the Official Gazette, the U.S. Patent and Trademark Office announced a new procedural framework that permits patent owners to submit a limited, early response to a request for ex parte reexamination.

...

Read More

© 2026 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.